CPCaroline Dalla Pozza

Caroline Dalla Pozza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Caroline Dalla Pozza has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Breaking Barriers: Reducing Costs and Overcoming Challenges in BCR::ABL-1 Monitoring for Chronic Myeloid Leukemia in Brazil

    by Ana Paula Beck da Silva Etges, Emanuela Pires, Caroline Pozza, Patrícia Ashton-Prolla, Claudia Astigarraga, Carisi Polanczyk

    PURPOSE: Tyrosine kinase inhibitors are available in the Brazilian public health care system. However, reimbursement challenges limit access to molecular testing of BCR::ABL-1 , which is essential for diagnosing and monitoring measurable residual disease in chronic myeloid leukemia (CML). This study estimated the costs associated with delivering the BCR::ABL-1 test in a tertiary academic reference care center in Brazil and simulated alternatives to increase patient access to the test. METHODS: This is an economic analysis that estimates the costs based on resource consumption from a hospital to deliver a specific health care service, following the steps of the time-driven activity-based costing method at an academic reference center in Brazil. With the costs per test calculated, a scenario analysis estimated the budget impact resulting from an increase in test volume and a decrease in kit purchase cost, considering the local incidence of the disease. RESULTS: The cost per test was R$717, and if only laboratory reagents and personnel were considered, delivering the test to one patient accounted for R$556, whereas the current reimbursement fee is R$144. The simulated scenarios indicate that by increasing the volume of tests delivered by 60% and renegotiating the acquisition cost with the supplier in the same proportion, it is possible to cover 63% of the regional demand without increasing the budget impact. CONCLUSION: The financial and access challenges explored in this study underscore the importance of accelerating more effective and sustainable health policies in the CML field, which include access to the BCR::ABL-1 test with financial accountability.

  • Length of stay in the clinical wards in a hospital after introducing a multiprofessional discharge team: An effectiveness improvement report

    by Mariana R. R. Falcetta, Dimitris V. Rados, Karine Molina, Daiana Oliveira, Caroline Dalla Pozza, Beatriz D. Schaan

    Introduction: Emergency overcrowding is a problem in hospitals worldwide. The expansion of wards has limitations. Hospital administrative leaders are constantly looking for opportunities to improve the efficiency of resource use.Methods: This is a care improvement study with a quasi‐experimental design. We created a hospital discharge team (HDT) to solve the issues of prolonged hospital stays. The main interventions were active search and resolution of prolongation of stay and multi‐disciplinary huddles. We developed strategies with different hospital units to expedite the processing of patients near discharge. Length of stay (LOS), morning hospital discharges, readmission rates, and bed usage were compared before (2018) and after (2019) HDT implementation.Results: There was a reduction in the mean LOS of 1.8 days (95% confidence interval [CI] −0.9 to −2.6; p < .001). The rate of hospital discharges before noon increased by 7.0% (95% CI 4%–11%; p < .001). The readmission rate was similar between 2018 and 2019 (+0.7%; 95% CI −0.1% to 1.9%; p = .358). We observed higher bed turnover, with 0.5 more hospitalizations per bed per month (95% CI 0.1–0.7; p = .01; mean of 3.7 ± 0.3 in 2018 and 4.1 ± 0.3 in 2019).Conclusion: HDT brought benefits to our hospital, reducing the length of stay and increasing bed turnover. However, there is a need for a team focused on the project and support from managers to overcome resistance and integrate units until they are fully operational.